Lonza Expands Service Platform to Viral Vaccines, Gene Therapy Vectors
Lonza Expands Service Platform to Viral Vaccines, Gene Therapy Vectors
Lonza (Basel, Switzerland) has entered the viral based–manufacturing market with its purchase of Vivante GMP Solutions, Inc. (Houston, TX). The acquisition advances Lonza’s strategy to broaden its biologics custom service offering for the growing viral vaccine and gene therapy markets.
Vivante is a custom manufacturing organization dedicated to producing GMP viral-based therapeutics. The company’s viral-vaccine production services will be enhanced by Lonza’s expertise in expression technologies and large-scale manufacturing platforms. Additionally, Vivante’s experience with preclinical through late-stage supply of viral vector–based products will compliment Lonza’s growing cellular and gene therapy process development and manufacturing capabilities.
Vivante’s employees have joined Lonza and will operate as Lonza’s viral-based therapeutics business.
Vivante operates a state-of-the-art GMP clean room facility including production and fill–finish capabilities, along with research and development and quality control operations. In addition to its GMP manufacturing service, Vivante offers process development and optimization, quality control analytical testing, and on- and off-site GMP product storage and distribution to clinical trial sites.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
